Price Table
| Date | Open | High | Low | Close | Volume | Delivery % | 20-Day sma | 50-Day sma | 200-Day sma |
|---|
View More
Day High Low Range
| Time | Lowest | Highest | Volume |
|---|
Past Performance & Moving Averages
| Day’s | Low high range | SMA | Stock performance | Nifty performance |
|---|
PIVOT POINTS
| NAME | S4 | S3 | S2 | S1 | PIVOT POINTS | R1 | R2 | R3 | R4 |
|---|---|---|---|---|---|---|---|---|---|
| CLASSIC | - | - | - | - | - | - | - | - | - |
| WOODIE‘S | - | - | - | - | |||||
| FIBONACCI | - | - | |||||||
| CAMARILLA | - |
Trend Analysis
Key Data
| Market cap | Book value | stock p/e | Dividend yield | roce | roe | sales growth (3Y) | face value (3Y) |
|---|
Profile
Unichem Laboratories Ltd. is a pharmaceutical company that was founded in 1944 in Mumbai, India. Over the years, the company has expanded its operations and has become a leading player in the generic drug market in India.
As of 2021, the company is performing well, with a strong presence in both the domestic and international markets. In the fiscal year 2020, the company had revenue of around INR 5,000 crore and a net profit of INR 126 crore.
The product mix of the company includes a range of generic drugs, which include anti-infectives, cardiovascular, central nervous system, gastroenterology, and respiratory, among others. These products account for the majority of the company's revenue and profit.
The major growth drivers for the future include the increasing demand for affordable healthcare, growth in emerging markets, and the increasing demand for generic drugs.
In terms of industry analysis, the pharmaceutical industry in India is highly competitive, with many players operating in the market. Some of the direct competitors of Unichem Laboratories Ltd. include Sun Pharmaceuticals, Cipla, and Dr. Reddy's Laboratories.
Trading and Investment Terminology